Cargando…

Promoter Methylation of MLH1, PMS2, MSH2 and p16 Is a Phenomenon of Advanced-Stage HCCs

Epigenetic silencing of tumour suppressor genes has been observed in various cancers. Looking at hepatocellular carcinoma (HCC) specific protein silencing was previously demonstrated to be associated with the Hepatitis C virus (HCV). However, the proposed HCV dependent promoter methylation of DNA mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hinrichsen, Inga, Kemp, Matthias, Peveling-Oberhag, Jan, Passmann, Sandra, Plotz, Guido, Zeuzem, Stefan, Brieger, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882222/ https://www.ncbi.nlm.nih.gov/pubmed/24400091 http://dx.doi.org/10.1371/journal.pone.0084453

Ejemplares similares

Reduced migration of MLH1 deficient colon cancer cells depends on SPTAN1
por: Hinrichsen, Inga, et al.
Publicado: (2014)

C-Terminal Fluorescent Labeling Impairs Functionality of DNA Mismatch Repair Proteins
por: Brieger, Angela, et al.
Publicado: (2012)

An Evaluation of the Immunohistochemical Expression of Mismatch Repair Proteins (MSH2, MSH6, MLH1, and PMS2) in Prostate Adenocarcinoma
por: Javeed, Saira, et al.
Publicado: (2022)

Mismatch Repair Proteins and Microsatellite Instability in Colorectal Carcinoma (MLH1, MSH2, MSH6 and PMS2): Histopathological and Immunohistochemical Study
por: Ismael, Nour El Hoda S., et al.
Publicado: (2017)

Key role of phosphorylation sites in ATPase domain and Linker region of MLH1 for DNA binding and functionality of MutLα
por: Firnau, May-Britt, et al.
Publicado: (2023)

MSH2 and MLH1 testing
por: Kurzawski, Grzegorz, et al.
Publicado: (2008)

Role for Mismatch Repair Proteins Msh2, Mlh1, and Pms2 in Immunoglobulin Class Switching Shown by Sequence Analysis of Recombination Junctions
por: Schrader, Carol E., et al.
Publicado: (2002)

Concurrent loss of MLH1, PMS2 and MSH6 immunoexpression in digestive system cancers indicating a widespread dysregulation in DNA repair processes
por: Reitsam, Nic Gabriel, et al.
Publicado: (2022)

The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers
por: Lawes, D A, et al.
Publicado: (2005)

Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer
por: Ackermann, Anne, et al.
Publicado: (2019)

Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast
por: Vogelsang, Matjaz, et al.
Publicado: (2009)

Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair
por: DuPrie, Matthew L., et al.
Publicado: (2022)

Loss of MSH6 and PMS2 immunohistochemical staining in tumour tissue of two individuals with a germline PMS2 mutation
por: Edwards, E, et al.
Publicado: (2012)

Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma
por: Shinsato, Yoshinari, et al.
Publicado: (2013)

A conserved motif in the disordered linker of human MLH1 is vital for DNA mismatch repair and its function is diminished by a cancer family mutation
por: Wolf, Karla, et al.
Publicado: (2023)

Population carrier frequency of hMSH2 and hMLH1 mutations
por: Dunlop, M G, et al.
Publicado: (2000)

Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer
por: Haron, Nor Hasyimah, et al.
Publicado: (2019)

Functional examination of MLH1, MSH2, and MSH6 intronic mutations identified in Danish colorectal cancer patients
por: Petersen, Sanne M, et al.
Publicado: (2013)

Prevalence and spectrum of MLH1, MSH2, and MSH6 pathogenic germline variants in Pakistani colorectal cancer patients
por: Rashid, Muhammad Usman, et al.
Publicado: (2019)

Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort
por: Rosty, Christophe, et al.
Publicado: (2016)

Functional characterization of MLH1 missense variants unveils mechanisms of pathogenicity and clarifies role in cancer
por: Mahdouani, Marwa, et al.
Publicado: (2022)

UMD-MLH1/MSH2/MSH6 databases: description and analysis of genetic variations in French Lynch syndrome families
por: Grandval, Philippe, et al.
Publicado: (2013)

Mlh1 Can Function in Antibody Class Switch Recombination Independently of Msh2
por: Schrader, Carol E., et al.
Publicado: (2003)

Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers
por: Dowty, JG, et al.
Publicado: (2012)

Novel Mutations in MLH1 and MSH2 Genes in Mexican Patients with Lynch Syndrome
por: Moreno-Ortiz, Jose Miguel, et al.
Publicado: (2016)

Expression of hMLH1 and hMSH2 proteins in ameloblastomas and tooth germs
por: Bologna-Molina, Ronell, et al.
Publicado: (2018)

Identification of MLH2/hPMS1 dominant mutations that prevent DNA mismatch repair function
por: Reyes, Gloria X., et al.
Publicado: (2020)

Next generation sequencing to decipher concurrent loss of PMS2 and MSH6 in colorectal cancer
por: Moreno, Esther, et al.
Publicado: (2020)

Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management
por: Ramsoekh, Dewkoemar, et al.
Publicado: (2009)

Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome
por: Schneider, Nayê Balzan, et al.
Publicado: (2018)

High Expression of Casein Kinase 2 Alpha Is Responsible for Enhanced Phosphorylation of DNA Mismatch Repair Protein MLH1 and Increased Tumor Mutation Rates in Colorectal Cancer
por: Ulreich, Katharina, et al.
Publicado: (2022)

Handcuffing intrinsically disordered regions in Mlh1–Pms1 disrupts mismatch repair
por: Furman, Christopher M, et al.
Publicado: (2021)

Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal human tissues.
por: Fink, D., et al.
Publicado: (1997)

Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers
por: Olschwang, Sylviane, et al.
Publicado: (2009)

Clinical significance of MLH1/MSH2 for stage II/III sporadic colorectal cancer
por: Wang, Shui-Ming, et al.
Publicado: (2019)

Hesperetin effect on MLH1 and MSH2 expression on breast cancer cells BT-549
por: Hasan, Assim Khattab, et al.
Publicado: (2023)

Investigation of the Wilson gene ATP7B transcriptional start site and the effect of core promoter alterations
por: Höflich, Clemens, et al.
Publicado: (2021)

Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families
por: Thodi, Georgia, et al.
Publicado: (2010)

Identification of new genetic alterations in MLH1, MSH2 and MSH6 using IHC and HRM analysis in Lynch syndrome-suspected patients
por: Mazurek, A, et al.
Publicado: (2012)

Targeted Next-Generation Sequencing of MLH1, MSH2, and MSH6 Genes in Patients with Endometrial Carcinoma under 50 Years of Age
por: Özdemir, Taha Reşid, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_loenqe426l8b1shs8dnqpqagl7